5-(4-tert-Butyl-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline

ID: ALA79089

PubChem CID: 10065779

Max Phase: Preclinical

Molecular Formula: C21H22N2

Molecular Weight: 302.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1ccc(C2=Cc3ccccc3C3=NCCN23)cc1

Standard InChI:  InChI=1S/C21H22N2/c1-21(2,3)17-10-8-15(9-11-17)19-14-16-6-4-5-7-18(16)20-22-12-13-23(19)20/h4-11,14H,12-13H2,1-3H3

Standard InChI Key:  AOAPRAZBFITKHR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 23 26  0  0  0  0  0  0  0  0999 V2000
    2.6417   -2.4667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6792   -1.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1667   -1.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6167   -2.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1292   -3.3750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.6292   -1.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2792   -1.8875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0667   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4667   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5667   -1.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5750   -2.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1750   -2.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1667   -1.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1667   -2.7750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1667   -3.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0792   -2.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1167   -1.5292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3750   -2.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3667   -1.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6667   -1.8792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5667   -2.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5875   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  2  0
  5  2  1  0
  6  2  2  0
  7  4  1  0
  8  3  1  0
  9 10  1  0
 10 13  2  0
 11  8  1  0
 12  8  2  0
 13 12  1  0
 14 11  2  0
 15  1  1  0
 16 15  1  0
 17  5  1  0
 18  7  1  0
 19  9  1  0
 20  9  1  0
 21  9  1  0
 22 17  2  0
 23 18  2  0
  6 16  1  0
  5  7  2  0
 14 10  1  0
 23 22  1  0
M  END

Associated Targets(Human)

PTAFR Tchem Platelet activating factor receptor (2575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abelson 8.1 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
YAC-1 (251 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 302.42Molecular Weight (Monoisotopic): 302.1783AlogP: 4.56#Rotatable Bonds: 1
Polar Surface Area: 15.60Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.16CX LogP: 4.61CX LogD: 4.41
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.75Np Likeness Score: -0.46

References

1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA..  (1995)  Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.,  38  (2): [PMID:7830265] [10.1021/jm00002a004]

Source